GENOMIC TESTING FOR EFFECTIVE THERAPIES AND DETERMINATION OF DOSING STRATEGY
摘要
Several embodiments disclosed herein relate to methods for calculating a dosing regimen that is tailored specifically to the genetic and metabolic profile of a particular patient. In some embodiments, the dosing regimen is related to administration of the antipsychotic drug clozapine, and the tailoring of the regimen reduces risk of adverse side effects.
申请公布号
WO2015143379(A1)
申请公布日期
2015.09.24
申请号
WO2015US21846
申请日期
2015.03.20
申请人
COMPANION DX REFERENCE LAB, LLC
发明人
ROSENBLATT, KEVIN, P.;GURNANI, PREM, P.;LASECKI, DAVD, W.